{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:45:08Z","timestamp":1783593908198,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/bjc.2017.156","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T22:46:08Z","timestamp":1496357168000},"page":"89-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells"],"prefix":"10.1038","volume":"117","author":[{"given":"Yu-Xin","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Flamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen G","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"issue":"16","key":"BFbjc2017156_CR1","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.18632\/oncotarget.2235","volume":"5","author":"N Babae","year":"2014","unstructured":"Babae N, Bourajjaj M, Liu Y, Van Beijnum JR, Cerisoli F, Scaria PV, Verheul M, Van Berkel MP, Pieters EH, Van Haastert RJ (2014) Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma. Oncotarget 5 (16): 6687.","journal-title":"Oncotarget"},{"key":"BFbjc2017156_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fgene.2012.00120","volume":"3","author":"AG Bader","year":"2012","unstructured":"Bader AG (2012) miR-34\u2013a microRNA replacement therapy is headed to the clinic. Front Genet 3: 120.","journal-title":"Front Genet"},{"issue":"1","key":"BFbjc2017156_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1472-6750-11-70","volume":"11","author":"I Balcells","year":"2011","unstructured":"Balcells I, Cirera S, Busk PK (2011) Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol 11 (1): 70.","journal-title":"BMC Biotechnol"},{"issue":"7403","key":"BFbjc2017156_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y (2012) The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature 486 (7403): 346\u2013352.","journal-title":"Nature"},{"issue":"2","key":"BFbjc2017156_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/bjc.2015.206","volume":"113","author":"F D\u2019Aiuto","year":"2015","unstructured":"D\u2019Aiuto F, Callari M, Dugo M, Merlino G, Musella V, Miodini P, Paolini B, Cappelletti V, Daidone M (2015) miR-30e* is an independent subtype-specific prognostic marker in breast cancer. Br J Cancer 113 (2): 290\u2013298.","journal-title":"Br J Cancer"},{"issue":"10","key":"BFbjc2017156_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/jnci\/djq102","volume":"102","author":"G Di Leva","year":"2010","unstructured":"Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H (2010) MicroRNA cluster 221-222 and estrogen receptor \u03b1 interactions in breast cancer. J Natl Cancer Inst 102 (10): 706\u2013721.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"BFbjc2017156_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.gene.2015.08.004","volume":"574","author":"S Eissa","year":"2015","unstructured":"Eissa S, Matboli M, Sharawy A, El-Sharkawi F (2015) Prognostic and biological significance of microRNA-221 in breast cancer. Gene 574 (1): 163\u2013167.","journal-title":"Gene"},{"issue":"4","key":"BFbjc2017156_CR8","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ccr.2013.09.008","volume":"24","author":"B Ell","year":"2013","unstructured":"Ell B, Mercatali L, Ibrahim T, Campbell N, Schwarzenbach H, Pantel K, Amadori D, Kang Y (2013) Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell 24 (4): 542\u2013556.","journal-title":"Cancer Cell"},{"issue":"5","key":"BFbjc2017156_CR9","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015a) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (5): E359\u2013E386.","journal-title":"Int J Cancer"},{"issue":"5","key":"BFbjc2017156_CR10","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015b) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (5): E359\u2013E386.","journal-title":"Int J Cancer"},{"issue":"35","key":"BFbjc2017156_CR11","doi-asserted-by":"publisher","first-page":"13021","DOI":"10.1073\/pnas.0803304105","volume":"105","author":"JA Foekens","year":"2008","unstructured":"Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA, Martens JW (2008) Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 105 (35): 13021\u201313026.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"BFbjc2017156_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.18632\/oncotarget.1682","volume":"5","author":"P Gasparini","year":"2014","unstructured":"Gasparini P, Cascione L, Fassan M, Lovat F, Guler G, Balci S, Irkkan C, Morrison C, Croce CM, Shapiro CL, Huebner K (2014) microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget 5 (5): 1174\u20131184.","journal-title":"Oncotarget"},{"issue":"7308","key":"BFbjc2017156_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"H Guo","year":"2010","unstructured":"Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466 (7308): 835\u2013840.","journal-title":"Nature"},{"issue":"6","key":"BFbjc2017156_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6 (6): 590\u2013610.","journal-title":"Mol Oncol"},{"issue":"1","key":"BFbjc2017156_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20100859","volume":"432","author":"L Jiang","year":"2010","unstructured":"Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A, Wang A, Dai Y, Zhou X (2010) MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 432 (1): 199\u2013205.","journal-title":"Biochem J"},{"issue":"10","key":"BFbjc2017156_CR16","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1158\/0008-5472.CAN-07-6639","volume":"68","author":"B Kefas","year":"2008","unstructured":"Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, Purow B (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68 (10): 3566\u20133572.","journal-title":"Cancer Res"},{"issue":"8","key":"BFbjc2017156_CR17","doi-asserted-by":"publisher","first-page":"e42895","DOI":"10.1371\/journal.pone.0042895","volume":"7","author":"S Kulkarni","year":"2012","unstructured":"Kulkarni S, Augoff K, Rivera L, McCue B, Khoury T, Groman A, Zhang L, Tian L, Sossey-Alaoui K (2012) Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer. PLoS One 7 (8): e42895.","journal-title":"PLoS One"},{"issue":"7","key":"BFbjc2017156_CR18","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.cell.2005.10.040","volume":"123","author":"X Li","year":"2005","unstructured":"Li X, Carthew RW (2005) A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye. Cell 123 (7): 1267\u20131277.","journal-title":"Cell"},{"issue":"1-2","key":"BFbjc2017156_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11010-013-1707-6","volume":"381","author":"Z Li","year":"2013","unstructured":"Li Z, Li N, Wu M, Li X, Luo Z, Wang X (2013) Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4. Mol Cell Biochem 381 (1-2): 233\u2013242.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"BFbjc2017156_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bbrc.2007.09.007","volume":"363","author":"Z Liang","year":"2007","unstructured":"Liang Z, Wu H, Reddy S, Zhu A, Wang S, Blevins D, Yoon Y, Zhang Y, Shim H (2007) Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Biochem Biophys Res Commun 363 (3): 542\u2013546.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"BFbjc2017156_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3892\/ijo.2014.2322","volume":"44","author":"Z Liu","year":"2014","unstructured":"Liu Z, Jiang Z, Huang J, Huang S, Li Y, Yu S, Yu S, Liu X (2014) miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K\/ATK and Raf\/MEK\/ERK pathways. Int J Oncol 44 (5): 1571\u20131580.","journal-title":"Int J Oncol"},{"issue":"3","key":"BFbjc2017156_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/carcin\/bgt354","volume":"35","author":"J Lu","year":"2014","unstructured":"Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang L, Xu X, Peng X, Li G, Tian W (2014) miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis 35 (3): 554\u2013563.","journal-title":"Carcinogenesis"},{"issue":"Suppl 1","key":"BFbjc2017156_CR23","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1479-5876-10-S1-S2","volume":"10","author":"M Masuda","year":"2012","unstructured":"Masuda M, Miki Y, Hata S, Takagi K, Sakurai M, Ono K, Suzuki K, Yang Y, Abe E, Hirakawa H (2012) An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma. J Transl Med 10 (Suppl 1): S2.","journal-title":"J Transl Med"},{"key":"BFbjc2017156_CR24","doi-asserted-by":"publisher","first-page":"497280","DOI":"10.1155\/2015\/497280","volume":"2015","author":"A Mondadori dos Santos","year":"2015","unstructured":"Mondadori dos Santos A, Metzinger L, Haddad O, M\u2019Baya-Moutoula E, Taibi F, Charnaux N, Massy ZA, Hlawaty H, Metzinger-Le Meuth V (2015) miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress. BioMed Res Int 2015: 497280.","journal-title":"BioMed Res Int"},{"issue":"6824","key":"BFbjc2017156_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (6824): 50\u201356.","journal-title":"Nature"},{"issue":"1","key":"BFbjc2017156_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1101\/gr.157901","volume":"11","author":"MV Myakishev","year":"2001","unstructured":"Myakishev MV, Khripin Y, Hu S, Hamer DH (2001) High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers. Genome Res 11 (1): 163\u2013169.","journal-title":"Genome Res"},{"issue":"9","key":"BFbjc2017156_CR27","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT\u2013PCR. Nucleic Acids Res 29 (9): e45\u2013e45.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"BFbjc2017156_CR28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.4161\/cbt.26370","volume":"14","author":"S Rani","year":"2013","unstructured":"Rani S, Gately K, Crown J, O\u2019Byrne K, O\u2019Driscoll L (2013) Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma. Cancer Biol Ther 14 (12): 1104\u20131112.","journal-title":"Cancer Biol Ther"},{"issue":"20","key":"BFbjc2017156_CR29","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1158\/0008-5472.CAN-08-2103","volume":"68","author":"SDN Reddy","year":"2008","unstructured":"Reddy SDN, Ohshiro K, Rayala SK, Kumar R (2008) MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 68 (20): 8195\u20138200.","journal-title":"Cancer Res"},{"issue":"9805","key":"BFbjc2017156_CR30","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/S0140-6736(11)61539-0","volume":"378","author":"JS Reis-Filho","year":"2011","unstructured":"Reis-Filho JS, Pusztai L (2011) Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 378 (9805): 1812\u20131823.","journal-title":"Lancet"},{"issue":"2","key":"BFbjc2017156_CR31","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/bcr3415","volume":"15","author":"M Riaz","year":"2013","unstructured":"Riaz M, van Jaarsveld M, Hollestelle A, Prager-van der Smissen W, Heine A, Boersma A, Liu J, Helmijr J, Ozturk B, Smid M (2013) miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Res 15 (2): R33.","journal-title":"Breast Cancer Res"},{"issue":"19","key":"BFbjc2017156_CR32","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1200\/JCO.2014.55.4139","volume":"32","author":"GW Sledge","year":"2014","unstructured":"Sledge GW, Mamounas EP, Hortobagyi GN, Burstein HJ, Goodwin PJ, Wolff AC (2014) Past, present, and future challenges in breast cancer treatment. J Clin Oncol 32 (19): 1979\u20131986.","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc2017156_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yexcr.2005.04.011","volume":"308","author":"K Sossey-Alaoui","year":"2005","unstructured":"Sossey-Alaoui K, Ranalli TA, Li X, Bakin AV, Cowell JK (2005) WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res 308 (1): 135\u2013145.","journal-title":"Exp Cell Res"},{"issue":"6","key":"BFbjc2017156_CR34","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2353\/ajpath.2007.060975","volume":"170","author":"K Sossey-Alaoui","year":"2007","unstructured":"Sossey-Alaoui K, Safina A, Li X, Vaughan MM, Hicks DG, Bakin AV, Cowell JK (2007) Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol 170 (6): 2112\u20132121.","journal-title":"Am J Pathol"},{"issue":"3","key":"BFbjc2017156_CR35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/carcin\/bgu242","volume":"36","author":"T Suto","year":"2015","unstructured":"Suto T, Yokobori T, Yajima R, Morita H, Fujii T, Yamaguchi S, Altan B, Tsutsumi S, Asao T, Kuwano H (2015) MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation. Carcinogenesis 36 (3): 338\u2013345.","journal-title":"Carcinogenesis"},{"issue":"1","key":"BFbjc2017156_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrm2069","volume":"8","author":"T Takenawa","year":"2007","unstructured":"Takenawa T, Suetsugu S (2007) The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 8 (1): 37\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7175","key":"BFbjc2017156_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (7175): 147\u2013152.","journal-title":"Nature"},{"issue":"2","key":"BFbjc2017156_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10549-013-2753-1","volume":"142","author":"MA Taylor","year":"2013","unstructured":"Taylor MA, Davuluri G, Parvani JG, Schiemann BJ, Wendt MK, Plow EF, Schiemann WP, Sossey-Alaoui K (2013) Upregulated WAVE3 expression is essential for TGF-beta-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Res Treat 142 (2): 341\u2013353.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"BFbjc2017156_CR39","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10637-015-0281-z","volume":"33","author":"R van der Noll","year":"2015","unstructured":"van der Noll R, Smit W, Wymenga A, Boss D, Grob M, Huitema A, Rosing H, Tibben M, Keessen M, Rehorst H, Beijnen JH, Schellens JH (2015) Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer. Invest New Drugs 33 (6): 1197\u20131205.","journal-title":"Invest New Drugs"},{"issue":"5","key":"BFbjc2017156_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/iub.1273","volume":"66","author":"B Wang","year":"2014","unstructured":"Wang B, Li J, Sun M, Sun L, Zhang X (2014) MiRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. IUBMB Life 66 (5): 371\u2013377.","journal-title":"IUBMB Life"},{"issue":"1","key":"BFbjc2017156_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clinre.2015.05.022","volume":"40","author":"Y-L Wang","year":"2015","unstructured":"Wang Y-L, Chen C-M, Wang X-M, Wang L (2015) Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 40 (1): 51\u201356.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"BFbjc2017156_CR42","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/1471-2407-10-542","volume":"10","author":"Z-S Wu","year":"2010","unstructured":"Wu Z-S, Wu Q, Wang C-Q, Wang X-N, Wang Y, Zhao J-J, Mao S-S, Zhang G-H, Zhang N, Xu X-C (2010) MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer 10 (1): 542.","journal-title":"BMC Cancer"},{"key":"BFbjc2017156_CR43","first-page":"144","volume":"8","author":"R W\u00fcrth","year":"2014","unstructured":"W\u00fcrth R, Bajetto A, Harrison JK, Barbieri F, Florio T (2014) CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front Cell Neurosci 8: 144.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"BFbjc2017156_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2407-14-49","volume":"14","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Ni C, Chen W, Wu P, Wang Z, Yin J, Huang J, Qiu F (2014) Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis. BMC Cancer 14 (1): 49.","journal-title":"BMC Cancer"},{"issue":"5","key":"BFbjc2017156_CR45","doi-asserted-by":"publisher","first-page":"e96718","DOI":"10.1371\/journal.pone.0096718","volume":"9","author":"X Zhou","year":"2014","unstructured":"Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang W, Di W, Qiu L (2014) MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT\/ERK1\/2 inactivation by targeting EGFR in epithelial ovarian cancer. PLoS One 9 (5): e96718.","journal-title":"PLoS One"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2017156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:38:01Z","timestamp":1684417081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2017156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFbjc2017156"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.156","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"22 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}